HIV Policy and Advocacy

Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.

Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

AIDS United quickly revised the conference when it became clear that the COVID-19 crisis would shut down the longstanding IRL version.

Advocates and public health organizations say the 2015 policy revision still stigmatizes gay men and isn’t based on science.

Thirty years ago, the NIH legend deftly negotiated between bureaucrats and activists. As part of Trump’s COVID-19 team, can he negotiate between loyalty and truth?

Activist and member of the state task force Annette Gaudino would like the public to know.

Many HIV service organizations say they’re open to hiring TGNC employees, but advocates say most have a long way to go.

The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.

Advocate D. Rashaan Gilmore explains how white-led HIV organizations in the U.S. engage in movement capture—e.g., the co-opting of Black racial justice efforts—under the guise of ending the HIV epidemic.